folfox
Showing 1 - 25 of 52
Metastatic Colorectal Cancer, CRC, KRAS/NRAS Mutation Trial (Onvansertib, FOLFIRI, Bevacizumab)
Not yet recruiting
- Metastatic Colorectal Cancer
- +2 more
- Onvansertib
- +3 more
- (no location specified)
Oct 24, 2023
Intrahepatic Cholangiocarcinoma Trial in Tianjin (Regorafenib and HAIC, FOLFOX)
Not yet recruiting
- Intrahepatic Cholangiocarcinoma
- Regorafenib and HAIC
- FOLFOX
-
Tianjin, ChinaTianjin Medical University Cancer Institute and Hospital
Sep 7, 2022
Advanced Rectal Cancer Trial in Rochester (FOLFOX)
Active, not recruiting
- Advanced Rectal Cancer
- FOLFOX
-
Rochester, New York
- +1 more
Jun 9, 2022
Unresectable Metastatic Colorectal Cancer Trial in Belgium, United States (CYAD-101, FOLFOX, Pembrolizumab)
Recruiting
- Unresectable Metastatic Colorectal Cancer
- CYAD-101
- +2 more
-
Jacksonville, Florida
- +4 more
Feb 22, 2022
Metastatic Colorectal Carcinoma Trial (Pentoxifylline, FOLFOX, XELOX)
Not yet recruiting
- Metastatic Colorectal Carcinoma
- Pentoxifylline
- +3 more
- (no location specified)
Nov 1, 2023
Malignant Tumor of Stomach Stage IV Trial in Fuzhou (POF, FOLFOX, FOLFOX plus PAC(ip))
Completed
- Malignant Neoplasm of Stomach Stage IV
- POF
- +2 more
-
Fuzhou, Fujian, ChinaRongbo Lin
Apr 22, 2021
Colonic Tumors Trial (Dostarlimab, CAPEOX, FOLFOX)
Not yet recruiting
- Colonic Neoplasms
- Dostarlimab
- +2 more
- (no location specified)
May 3, 2023
Gastroesophageal Adenocarcinoma Trial in Orange (device, combination product, drug)
Not yet recruiting
- Gastroesophageal Adenocarcinoma
- ctDNA Blood Test
- +8 more
-
Orange, CaliforniaChao Family Comprehensive Cancer Center, University
Feb 8, 2023
Rectal Adenocarcinoma Trial in Milwaukee (Capecitabine, Initial Dose of Radiation before Dose Escalation, Cohort A: Dose
Recruiting
- Rectal Adenocarcinoma
- Capecitabine
- +5 more
-
Milwaukee, WisconsinFroedtert & the Medical College of Wisconsin
Jul 19, 2022
Unresectable Adenocarcinoma of the Esophagus, Metastatic Adenocarcinoma of the Esophagus, Unresectable Adenocarcinoma of Gastric
Completed
- Unresectable Adenocarcinoma of the Esophagus
- +3 more
- FOLFOX
- +2 more
-
Los Angeles, California
- +1 more
Sep 3, 2021
Operable T2-3N+M0 Rectal Cancer (Stage III) Trial in Canada (FOLFOX, high dose rate endorectal brachytherapy)
Active, not recruiting
- Operable T2-3N+M0 Rectal Cancer (Stage III)
- FOLFOX
- high dose rate endorectal brachytherapy
-
Gatineau, Quebec, Canada
- +7 more
May 13, 2021
Hepatocellular Carcinoma Trial in Beijing (HAIC, TACE, FOLFOX)
Recruiting
- Hepatocellular Carcinoma
- HAIC
- +4 more
-
Beijing, Beijing, ChinaPeking University Cancer Hospital
Jan 10, 2022
Pancreatic Adenocarcinoma Trial in Paris (Gemcitabine, FOLFOX)
Recruiting
- Pancreatic Adenocarcinoma
- Gemcitabine
- FOLFOX
-
Paris, FranceAPHP - Groupe Hospitalier Pitié-Salpêtrière
Aug 17, 2020
Unresectable Metastatic Colorectal Cancer Trial in Belgium, United States (CYAD-101, FOLFOX, FOLFIRI)
Recruiting
- Unresectable Metastatic Colorectal Cancer
- CYAD-101
- +2 more
-
Tampa, Florida
- +3 more
Nov 19, 2020
Pancreatic Cancer Trial in Worldwide (Pegilodecakin, FOLFOX)
Completed
- Pancreatic Cancer
- Pegilodecakin
- FOLFOX
-
Gilbert, Arizona
- +129 more
Sep 24, 2020
Metastatic Colorectal Cancer Trial in Worldwide (Inavolisib, Bevacizumab, Cetuximab)
Recruiting
- Metastatic Colorectal Cancer
- Inavolisib
- +7 more
-
Birmingham, Alabama
- +36 more
Dec 29, 2022
Gastric Cancer, Cancer of the Stomach, Esophagogastric Junction Trial in Worldwide (BMS-986213, Nivolumab, XELOX)
Active, not recruiting
- Gastric Cancer
- +2 more
- BMS-986213
- +4 more
-
Clovis, California
- +77 more
Jan 9, 2023
Advanced Solid Tumors, Kirsten Rat Sarcoma (KRAS) pG12C Mutation Trial in Worldwide (Sotorasib, AMG 404, trametinib)
Recruiting
- Advanced Solid Tumors
- Kirsten Rat Sarcoma (KRAS) pG12C Mutation
- Sotorasib
- +15 more
-
Tucson, Arizona
- +83 more
Dec 28, 2022